false
OasisLMS
Login
Catalog
2026 SSC Children Guidelines Updates: What Clinici ...
Surviving Sepsis Campaign Children's Guidelines: 2 ...
Surviving Sepsis Campaign Children's Guidelines: 2026 Update - Handouts
Back to course
Pdf Summary
The document summarizes a Society of Critical Care Medicine (SSC) webinar (April 7, 2026) on the 2026 SSC Children’s Sepsis Guidelines updates, focusing on hemodynamic resuscitation, adjunct therapies, and follow-up. The guideline process used GRADE (strong vs conditional recommendations and good practice statements). The panel noted major evidence limitations: 27 of 29 recommendations are based on low/very low certainty, and for 22 topics the panel could issue no recommendation or only a good practice statement. <strong>Hemodynamic resuscitation and fluids:</strong> For septic shock with ICU available, clinicians should give up to 40–60 mL/kg bolus fluids (10–20 mL/kg per bolus) in the first hour; in settings without ICU, fluid boluses are discouraged for sepsis without hypotension, but suggested up to 40 mL/kg for hypotensive septic shock. Reassess after each bolus and stop if shock resolves or fluid overload develops. Crystalloids are preferred over albumin; balanced/buffered crystalloids are suggested over 0.9% saline due to similar mortality but possible lower AKI/RRT. <strong>Monitoring:</strong> Ongoing bedside clinical assessment remains central. Evidence was insufficient to define optimal MAP percentile targets. When central access is available, targeting ScvO₂ 70% is suggested. Evidence is insufficient for “advanced” hemodynamic monitoring, but cardiac/lung POCUS is suggested where training/resources allow, with small trials showing faster shock reversal and shorter ICU stay. <strong>Vasoactives:</strong> Evidence is insufficient on starting vasoactives before vs after 40 mL/kg fluids and on choosing epinephrine vs norepinephrine first-line. Starting vasoactives via peripheral IV rather than waiting for central access is suggested, with observational data indicating low extravasation risk and possible mortality benefit. For high-dose catecholamines, adding vasopressin or further titrating catecholamines is suggested; evidence is insufficient for inodilators, angiotensin II, or methylene blue. <strong>Adjunct therapies and follow-up:</strong> New/updated items include a conservative post-resuscitation oxygen target (SpO₂ 88–92%) for intubated children (moderate certainty), continued avoidance of etomidate, and insufficient evidence on intubation absent respiratory failure. Hydrocortisone is suggested against when stability is achievable with fluids/vasopressors; refractory shock has insufficient evidence. Fever management and bicarbonate for metabolic acidemia also have insufficient evidence. Vitamins C, thiamine, and routine vitamin D repletion are suggested against. Post-resuscitation fluid overload prevention and active removal earned a good practice statement. A major direction change: high-volume hemofiltration is now suggested for septic children requiring RRT. A new post-ICU section highlights frequent long-term morbidity, suggesting early rehab bundles and recommending risk assessment, education, and evaluation for post-sepsis sequelae.
Meta Tag
Concept
Pediatric Sepsis
Concept
Hemodynamic Resuscitation
Concept
Fluid Bolus
Concept
Hemodynamic Monitoring
Concept
Vasoactive Medication
Keywords
2026 SSC Children’s Sepsis Guidelines
pediatric septic shock
hemodynamic resuscitation
fluid bolus 40–60 mL/kg first hour
balanced crystalloids vs normal saline
ScvO2 target 70%
point-of-care ultrasound (POCUS) monitoring
peripheral vasoactive infusion
vasopressin for catecholamine-refractory shock
post-sepsis follow-up and rehabilitation
Pediatric Sepsis
Hemodynamic Resuscitation
Fluid Bolus
Hemodynamic Monitoring
Vasoactive Medication
×
Please select your language
1
English